Every Utah patient researching GLP-1 weight loss now runs into the same wall of ads: "GLP-1s delivered to your door," "no doctor visit required," "as low as $99/month." Here's what's actually behind those numbers — and what a physician-led clinic 20 minutes from Richfield looks like by comparison.
Search "semaglutide near me" or "tirzepatide Utah" today and telehealth subscriptions dominate the results, often with lower headline prices than an in-person clinic. That's not an accident — it's a business model built around minimizing overhead: no exam room, no in-house labs, no local pharmacy relationship.
That model works fine for some things. GLP-1 medications, taken for a year or longer with real dosing and side-effect considerations, generally aren't one of them. This page lays out exactly what the telehealth model typically includes and skips, what the safety and pricing data actually show, and how that compares to physician-led care in Salina.
Most low-cost telehealth GLP-1 subscriptions rely on compounded semaglutide or tirzepatide, not the FDA-approved brand product, to hit their advertised prices. That distinction matters — here's the regulatory record.
The FDA issued warning letters to more than 50 companies compounding or marketing semaglutide and tirzepatide, citing false or misleading claims on their websites and in promotional materials.
Source: FDA enforcement actions, reported by Wilson Sonsini & Pharmacy TimesThe FDA has logged hundreds of adverse event reports tied to compounded semaglutide and tirzepatide, many involving dosing errors from patients self-administering incorrect doses out of multidose vials — some requiring hospitalization.
Source: FDA adverse event data, reported by Stanford MedicineTirzepatide left the FDA's official shortage list in December 2024 and semaglutide in February 2025 — the designation that made broad compounding legal in the first place. In April 2026, the FDA proposed permanently excluding these drugs from the ingredient list large-scale compounders are allowed to use.
Source: FDA regulatory filings, reported by AJMC & Pharmacy TimesThe FDA has also flagged fraudulent compounded product on the market, including vials labeled with the names of pharmacies that never actually compounded the medication.
Source: FDA enforcement actionsTelehealth GLP-1 pricing is real — but it's rarely the number in the ad once you add what's disclosed at checkout.
A general comparison of the two common models for GLP-1 care — not a specific business.
Tirzepatide (Zepbound, Mounjaro) is one of the medications most aggressively marketed by telehealth compounders right now — which makes physician oversight even more relevant, not less. Abbott offers tirzepatide with the same in-person labs, dosing, and monitoring described above.
See the Full Tirzepatide Guide →"I'm not against telehealth broadly — it has a place. But GLP-1 medications aren't vitamins. Dosing has to be adjusted based on how you're actually responding, and that requires someone who can examine you, not just read a form you filled out."
Abbott serves Salina, Richfield, Manti, Gunnison, Ephraim, Mount Pleasant, and surrounding Central Utah communities in person — see our full Service Areas map, or find the guide built specifically for your town.
What Utah patients ask most before choosing between online and in-person GLP-1 care.
Book a consultation and get a real exam, real labs, and a plan built around how you actually respond — not a subscription and a shipping label.